Thomas H. Tulip - Net Worth and Insider Trading
Thomas H. Tulip Net Worth
The estimated net worth of Thomas H. Tulip is at least $2 dollars as of 2024-09-20. Thomas H. Tulip is the EVP & Chief Business Officer of Navidea Biopharmaceuticals Inc and owns about 2,297 shares of Navidea Biopharmaceuticals Inc (NAVB) stock worth over $2. Details can be seen in Thomas H. Tulip's Latest Holdings Summary section.
Disclaimer: The insider information is derived from SEC filings. The estimated net worth is based on the final shares held after open market or private purchases and sales of common stock with a transaction code of "P" or "S" on Form 4, assuming that Thomas H. Tulip has not made any transactions after 2013-03-15 and currently still holds the listed stock(s). Please note that this estimate may not reflect the actual net worth.
Transaction Summary of Thomas H. Tulip
Thomas H. Tulip Insider Ownership Reports
Based on ownership reports from SEC filings, as the reporting owner, Thomas H. Tulip owns 1 companies in total, including Navidea Biopharmaceuticals Inc (NAVB) .
Click here to see the complete history of Thomas H. Tulip’s form 4 insider trades.
Insider Ownership Summary of Thomas H. Tulip
| Ticker | Comapny | Transaction Date | Type of Owner |
|---|---|---|---|
| NAVB | Navidea Biopharmaceuticals Inc | 2013-03-15 | EVP & Chief Business Officer |
Thomas H. Tulip Latest Holdings Summary
Thomas H. Tulip currently owns a total of 1 stock. Thomas H. Tulip owns 2,297 shares of Navidea Biopharmaceuticals Inc (NAVB) as of March 15, 2013, with a value of $2.
Latest Holdings of Thomas H. Tulip
| Ticker | Comapny | Latest Transaction Date | Shares Owned | Current Price ($) | Current Value ($) |
|---|---|---|---|---|---|
| NAVB | Navidea Biopharmaceuticals Inc | 2013-03-15 | 2,297 | 0.00 | 2 |
Holding Weightings of Thomas H. Tulip
Thomas H. Tulip Form 4 Trading Tracker
According to the SEC Form 4 filings, Thomas H. Tulip has made a total of 0 transactions in Navidea Biopharmaceuticals Inc (NAVB) over the past 5 years. The most-recent trade in Navidea Biopharmaceuticals Inc is the acquisition of 875 shares on March 15, 2013, which cost Thomas H. Tulip around $49,350.
Insider Trading History of Thomas H. Tulip
- 1
Thomas H. Tulip Trading Performance
GuruFocus tracks the stock performance after each of Thomas H. Tulip's buying transactions within different timeframes. To be detailed, the average return of stocks after 3 months bought by Thomas H. Tulip is -1.18%. GuruFocus also compares Thomas H. Tulip's trading performance to market benchmark return within the same time period. The performance of stocks bought by Thomas H. Tulip within 3 months outperforms 1 times out of 2 transactions in total compared to the return of S&P 500 within the same period.
You can select different timeframes to see how Thomas H. Tulip's insider trading performs compared to the benchmark.
Performance of Thomas H. Tulip
Average Return
Outperforming Transactions
| 1 Month | 3 Months | 6 Months | 1 Year | 2 Years | 3 Years | |
|---|---|---|---|---|---|---|
| Return(%) | -7.46 | | | | | |
| Relative Return to S&P 500(%) | -5.93 | | | | | |
Thomas H. Tulip Ownership Network
Thomas H. Tulip Owned Company Details
What does Navidea Biopharmaceuticals Inc do?
Who are the key executives at Navidea Biopharmaceuticals Inc?
Thomas H. Tulip is the EVP & Chief Business Officer of Navidea Biopharmaceuticals Inc. Other key executives at Navidea Biopharmaceuticals Inc include Chief Financial Officer Craig Dais , director & 10 percent owner Scott John K Jr. , and Chief Regulatory Officer Michel Mikhail .
Navidea Biopharmaceuticals Inc (NAVB) Insider Trades Summary
In summary, during the past 3 months, insiders sold 0 shares of Navidea Biopharmaceuticals Inc (NAVB) in total and bought 0 shares, with a net sale of 0 shares. During the past 18 months, 0 shares of Navidea Biopharmaceuticals Inc (NAVB) were sold and 0 shares were bought by its insiders, resulting in a net sale of 0 shares.
Navidea Biopharmaceuticals Inc (NAVB)'s detailed insider trading history can be found in Insider Trading Tracker table.
Navidea Biopharmaceuticals Inc Insider Transactions
Thomas H. Tulip Mailing Address
Above is the net worth, insider trading, and ownership report for Thomas H. Tulip. You might contact Thomas H. Tulip via mailing address: 425 Metro Place N., Suite 300, Dublin Oh 43017.
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
